ABSTRACT. Staphylococcus hyicus isolates (n=207), including 150 exfolitative toxigenic and 57 non-toxigenic strains, were examined for their susceptibility to 13 antimicrobial agents by using the dehydrated 96-well MIC panel system. The frequency of their resistance to penicillin and ampicillin was 76.8% (159/207), followed by erythromycin (56%, 116/207), trimethoprim-sulfamethoxazole (28.5%, 59/ 207), chloramphenicol (24.2%, 50/207), kanamycin (19.8%, 41/207), and doxycycline (1.4%, 3/207). Resistance to chloramphenicol and trimethoprim-sulfamethoxazole was significantly higher in toxigenic strains than non-toxigenic strains (p<0.01), whereas kanamycin and erythromycin resistance was significantly higher in non-toxigenic strains (p<0.01 and <0.05, respectively). Resistance to two or more antimicrobials was observed in 85.5% (177/207) of total strains, with a significantly higher occurrence in toxigenic strains (89.3%, 134/ 150 vs. 75.4%, 43/57; p<0.05).
Exfoliative toxins-producing Staphylococcus hyicus (toxigenic strains) have been implicated in causing porcine exudative epidermitis particularly in suckling and weaned pigs [4, 9, 15] . The isolation rate of toxigenic strains is reportedly four times higher in the pigs with exudative epidermitis than the healthy pigs [8] . Exudative epidermitis is frequently treated with antimicrobial agents, but successful treatment is complicated by the occurrence of antimicrobial resistance among S. hyicus strains. Antimicrobial resistance of the isolates from various animals including diseased pigs in different countries have been reported [1-3, 14, 16, 17] . However, antimicrobial resistance as to the toxin genes carriage in S. hyicus is not known.
This study aimed to determine the antimicrobial susceptibility of toxigenic and non-toxigenic S. hyicus strains from healthy pigs and pigs with exudative epidermitis in Japan, and to investigate the association between antimicrobial resistance and the carriage of toxin genes.
A total of 207 S. hyicus strains, including 150 exfolitative toxigenic strains and 57 non-toxigenic strains from exudative epidermitis and healthy pigs, isolated in 8 years between 1994 and 2002 from 17 prefectures in Japan and previously studied for their exfoliative toxigenes [8] , were included in this study. Minimal inhibitory concentration (MIC) determination was done by broth dilution method using the dehydrated 96-well MIC panel system (Eiken, Tokyo) following the Clinical and Laboratory Standards Institute (CLSI) guidelines. The following antimicrobials, the representatives of commonly used drug classes in Japan, were tested (with tested ranges indicated in parentheses); penicillin (0.06-8 g/ml), ampicillin (0.12-16 g/ml), oxacillin (0.25-4 g/ml), cefazolin (0.5-64 g/ml), cefuroxime (0.5-64 g/ml), gentamicin (0.5-64 g/ml), kanamycin (1-128 g/ml), erythromycin (0.25-32 g/ml), doxycycline (0.25-32 g/ml), vancomycin (0.5-16 g/ml), chloramphenicol (1-128 g/ml), trimethoprim-sulfamethoxazole (0.5 and 8-9.5 and 152 g/ml, respectively), and ofloxacin (0.12-16 g/ml). Staphylococcus aureus JCM 2874 (ATCC29213) and Escherichia coli JCM 5491 (ATCC25922) were included as controls. MIC breakpoints of susceptible (S), intermediate (I), and resistant (R), were taken from the CLSI [5] . Significance of differences between the variables was tested with the  2 test or the Fisher's extract test.
Antimicrobial resistance profile of 207 S. hyicus strains is shown in Table 1 . Intermediate resistance was observed only for doxycycline (1/207, 0.5%) and chloramphenicol (5/ 207, 2.4%), and is therefore not shown in the table. For total S. hyicus strains, the highest frequency of resistance was observed with penicillin and ampicillin (76.8%, 159/207), followed by erythromycin (56%, 116/207), trimethoprimsulfamethoxazole (28.5%, 59/207), chloramphenicol (24.2%, 50/207), kanamycin (19.8%, 41/207), and doxycycline (1.4%, 3/207). Resistance to chloramphenicol and trimethoprim-sulfamethoxazole was significantly higher in toxigenic strains than non-toxigenic strains (p<0.01), whereas kanamycin and erythromycin resistance was significantly higher in non-toxigenic strains (p<0.01 and <0.05, respectively).
Based on their antimicrobial resistance patterns, S. hyicus strains could be categorized into 14 distinctive groups (data not shown), with 5 predominant groups exhibiting resistance to at least 3 antimicrobials ( Table 2) . Out of five predominant resistance patterns, penicillin/ampicillin/ trimethoprim-sulfamethoxazole, penicillin/ampicillin/erythromycin/trimethoprim-sulfamethoxazole, and penicillin/ ampicillin/chloramphenicol were restricted to 16.7-19.3% of toxigenic strains only, whereas penicillin/ampicillin/kanamycin/erythromycin and penicillin/ampicillin/erythromycin patterns were common to both toxigenic and nontoxigenic strains, with a slightly higher occurrence in nontoxigenic strains. Resistance to two or more antimicrobials (multi-antimicrobial resistance) was observed in 85.5% (177/207) of total strains, with a significantly higher occurrence in toxigenic strains (89.3%, 134/150 vs. 75.4%, 43/57; p<0.05). All toxigenic and non-toxigenic strains were susceptible to oxacillin, cefazolin, cefuroxine, gentamicin, vancomycin, and ofloxacin, and all non-toxingenic strains were susceptible to chloramphenicol. Actually, most non-toxigenic strains (95%) are also susceptible to trimethoprim-sulfamethoxazole. Notably, all resistant strains displayed a double resistance to penicillin and ampicillin. There were only a few reports about antimicrobial susceptibility of S. hyicus in the past. In a previous study from Japan in 1987 [14] , the resistance rates for penicillin, erythromycin, and doxycycline were 38.7%, 41.1%, and 55.6%, respectively, by using the MIC breakpoints of 1.56 g/ml (penicillin), 12.5 g/ml (erythromycin), and 0.39 g/ml (doxycycline), whereas in our study, using the corresponding MIC breakpoints of 0.25 g/ml, 8.0 g/ml, and 16.0 g/ ml, the resistance rates were 76.8%, 56%, 1.4%, respectively. Finding very low doxycycline resistance was unexpected because tetracycline compounds share 43% of animal antimicrobial sales in Japan [13] , and oxytetracycline has been one of the feed additives.
Chloramphenicol resistance was 24.2% (50/207) over the study period. In fact, most chloramphenicol resistant strains (82%, 41/50) were isolated from 1994 to 1998; only nine strains (18%) were of 2002. Among the tested antimicrobials chloramphenicol, oxacillin, and vancomycin are not commonly used in food-producing animals. Chloramphenicol has been prohibited for use in food-producing animals since 1998. Increasing resistance up to 82% of chloramphenicol from indiscriminate use until 1998 was effectively averted by ban of its use, which is evident from only 18% resistance rate in 2002.
Our finding of high resistance to penicillin (76.8%) and erythromycin (56%) during 1994 to 2002 is comparable to the corresponding resistance (54-75% and 15-62%) in a Danish study over the period 1996-2001 [3] .
Staphylococcal bacterial toxins and antimicrobial resistance determinants are carried on mobile genetic elements such as plasmids, transposons, and prophages [10] . Chloramphenicol acetyltransferase genes (cat genes) and a trimethoprim-resistant dihydrofolate reductase have been reported in chromosomes and plasmids in a wide variety of Staphylococci [6, 7, 11, 12] . Despite there is a possibility of antimicrobial resistance genes residing together with exfoliative toxin genes in S. hyicus, we did not find any such occurrence in this study.
In conclusion, we did not find any significant correlation between the antimicrobial resistance and the toxin genes carriage or the isolation origin (i.e., from healthy or diseased pigs) among S. hyicus strains. Although methicillin-resistant Staphylococcus hyicus (MRSH) or vancomycin-resistant Staphylococcus hyicus (VRSH) were not detected in this study, like other staphylococci, S. hyicus strains showed a tendency toward increasing resistance to many antimicrobials. Therefore, sustained monitoring of resistance development in organisms of animal origin would be a prudent preventive measure against zoonotic infections in human.
